Bausch + lomb announces statistically significant results from a clinical study of a novel daily nutritional supplement for dry eyes

Vaughan, ontario--(business wire)--bausch + lomb corporation (nyse/tsx: blco), a leading global eye health company dedicated to helping people see better to live better, today announced frontiers in ophthalmology published statistically significant results from a clinical study evaluating the efficacy and safety of a novel daily nutritional supplement formulated to address the symptoms of dry eyes.1 bausch + lomb expects to launch the supplement, which features a proprietary blend of ingredient.
BLCO Ratings Summary
BLCO Quant Ranking